A number of other research analysts have also recently weighed in on CERN. UBS Group dropped their price objective on shares of Cerner from $84.00 to $82.00 and set a buy rating for the company in a research note on Wednesday, April 29th. Cowen raised shares of Cerner from a market perform rating to an outperform rating and set a $79.00 price objective for the company in a research note on Monday, March 30th. Stifel Nicolaus dropped their price objective on shares of Cerner from $81.00 to $75.00 in a research note on Wednesday, March 11th. Barclays dropped their price objective on shares of Cerner from $72.00 to $67.00 and set an equal weight rating for the company in a research note on Wednesday, April 29th. Finally, SunTrust Banks cut shares of Cerner from a buy rating to a hold rating and raised their price objective for the stock from $66.00 to $72.00 in a research note on Friday, May 1st. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and fifteen have given a buy rating to the company’s stock. The company has an average rating of Buy and an average price target of $78.80.
Shares of Cerner stock opened at $69.91 on Monday. Cerner has a 12-month low of $53.08 and a 12-month high of $80.90. The company has a current ratio of 1.93, a quick ratio of 1.90 and a debt-to-equity ratio of 0.35. The stock has a market cap of $21.15 billion, a PE ratio of 28.13, a price-to-earnings-growth ratio of 2.18 and a beta of 0.87. The company has a 50-day moving average of $69.37 and a two-hundred day moving average of $70.33.
The business also recently declared a quarterly dividend, which will be paid on Friday, July 17th. Shareholders of record on Friday, June 5th will be issued a $0.18 dividend. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.03%. Cerner’s dividend payout ratio (DPR) is presently 29.88%.
In other Cerner news, CEO David Brent Shafer sold 11,907 shares of Cerner stock in a transaction on Thursday, April 30th. The shares were sold at an average price of $69.73, for a total value of $830,275.11. Following the transaction, the chief executive officer now owns 37,756 shares in the company, valued at approximately $2,632,725.88. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP John Peterzalek sold 53,177 shares of Cerner stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $70.89, for a total transaction of $3,769,717.53. The disclosure for this sale can be found here. In the last quarter, insiders sold 133,834 shares of company stock worth $9,481,016. 0.33% of the stock is owned by company insiders.
Large investors have recently bought and sold shares of the stock. NWK Group Inc. acquired a new position in shares of Cerner during the 4th quarter valued at $33,000. NewSquare Capital LLC acquired a new position in shares of Cerner during the 1st quarter valued at $38,000. Simon Quick Advisors LLC lifted its holdings in shares of Cerner by 1,440.5% during the 1st quarter. Simon Quick Advisors LLC now owns 647 shares of the company’s stock valued at $41,000 after acquiring an additional 605 shares in the last quarter. Procyon Private Wealth Partners LLC acquired a new position in shares of Cerner during the 4th quarter valued at $45,000. Finally, Pacitti Group Inc. acquired a new position in shares of Cerner during the 4th quarter valued at $51,000. Institutional investors and hedge funds own 82.75% of the company’s stock.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Featured Story: How to interpret the current ratio
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.